Researcher

Bos, G.M.J.

Full professor - Specialised remit, H/MS

View graph of relations
  1. 2019
  2. Published
  3. Published
    Paulus, A., van Ewijk, P. A., Nascimento, E. B. M., De Saint-Hubert, M., Hendrikx, G., Vogg, A., ... Bauwens, M. (2019). Characterization of BAT activity in rats using invasive and non-invasive techniques. PLOS ONE, 14(5), 1-18. [0215852]. https://doi.org/10.1371/journal.pone.0215852
  4. Published
  5. 2018
  6. Published
  7. Published
  8. Published
  9. Published
    Habets, T. H. P. M., Hepkema, B. G., Kouprie, N., Schnijderberg, M. C. A., van Smaalen, T. C., Bungener, L. B., ... Vanderlocht, J. (2018). The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression. PLOS ONE, 13(9), [e0203381]. https://doi.org/10.1371/journal.pone.0203381
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
    Goldschmidt, H., Lokhorst, H. M., Mai, E. K., van der Holt, B., Blau, I. W., Zweegman, S., ... Sonneveld, P. (2018). Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial. Leukemia, 32(2), 383-390. https://doi.org/10.1038/leu.2017.211
  16. Published
  17. 2017
  18. Published
  19. Published
  20. Published
  21. Published
  22. 2016
  23. Published
    Nijhof, I. S., Franssen, L. E., Levin, M-D., Bos, G. M. J., Broijl, A., Klein, S. K., ... van de Donk, N. W. C. J. (2016). Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma. Blood, 128(19), 2297-2306. https://doi.org/10.1182/blood-2016-07-729236
  24. Published
  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
  30. Published
  31. 2015
  32. Published
  33. Published
  34. Published
  35. 2014
  36. Published
  37. Published
  38. Published
  39. 2012
  40. Published
  41. Published
  42. 2011
  43. Published
  44. Published
  45. 2010
  46. Published
  47. Published
    Van Elssen, C. H. M. J., Frings, P. W. H., Bot, F. J., Van de Vijver, K. K., Huls, M. B., Meek, B., ... Bos, G. M. J. (2010). Expression of aberrantly glycosylated Mucin-1 in ovarian cancer. Histopathology, 57(4), 597-606. https://doi.org/10.1111/j.1365-2559.2010.03667.x
  48. Published
  49. Published
  50. Published
  51. Published
  52. Published
    Meek, B., Cloosen, S., Borsotti, C., Van Elssen, C. H. M. J., Vanderlocht, J., Schnijderberg, M. C. A., ... Bos, G. M. J. (2010). In vitro-differentiated T/natural killer-cell progenitors derived from human CD34(+) cells mature in the thymus. Blood, 115(2), 261-264. https://doi.org/10.1182/blood-2009-05-223990
  53. Published
  54. 2007
  55. Published
  56. 2005
  57. Published
  58. Published
  59. Published
  60. 2004
  61. Published
  62. Published
Previous 1 2 Next